Table 3. Effects of infliximab treatment on RA parameters versus prednisolone-treated patients.

	Infliximab-treated RA patients (n = 20)			Prednisolone-treated RA patients (n = 18)
	Baseline	3-month	p-value	Baseline	3-month	p-value
CRP (mg/dl)	19.9 ± 6.4	4.7 ± 1.2	< 0.05	17.5 ± 7.5	5.6 ± 2.2	< 0.05
DAS-28	6.4 ± 1.0	5.4 ± 1.1	< 0.05	7.1 ± 0.7	6.2 ± 1.0	< 0.05
DASI	3.9 ± 0.8	6.8 ± 0.5	< 0.05	3.6 ± 1.0	6.1 ± 0.9	< 0.05

Values are expressed as mean ± SD.

CRP = C-reactive protein, DAS-28 = disease activity score 28, DASI = Duke activity status index.